Hemolytic-Uremic Syndrome - 2 Studies Found
Completed |
: Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS) : Shiga-like Toxin-producing Escherichia Coli : 2011-08-03 : Drug: Eculizumab (Soliris®) Eculizumab 300 mg, 600 mg, 900 mg or 1200 mg will be administered intra |
Withdrawn |
: The Plasma Large-Volume Exchange RCT :
|